Research work · 2020
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
Jonathan Wade Goldman, Mikhail Vladimirovich Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro V. Trukhin, Galina Statsenko, Maximilian Johannes Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Marina Chiara Garassino, Олександр Войтко, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Każarnowicz, György Losonczy, Nikolay Vladimirov Conev
The Lancet Oncology